MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Guardant Health Inc

Geschlossen

BrancheGesundheitswesen

65.54 3.36

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

63.43

Max

65.96

Schlüsselkennzahlen

By Trading Economics

Einkommen

-4.7M

-100M

Verkäufe

29M

232M

Gewinnspanne

-43.044

Angestellte

1,999

EBITDA

22M

-89M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+9.32% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

2.4B

7.9B

Vorheriger Eröffnungskurs

62.18

Vorheriger Schlusskurs

65.54

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

Guardant Health Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

8. Okt. 2025, 20:45 UTC

Ergebnisse

Costco Wholesale Sales Climb in September, Early October

8. Okt. 2025, 20:12 UTC

Wichtige Markttreiber
Akquisitionen, Fusionen, Übernahmen

TaskUs Shares Fall After Holders Reject Take-Private Deal

8. Okt. 2025, 16:39 UTC

Wichtige Markttreiber

Mining Shares Rise as Gold Prices Soar

8. Okt. 2025, 23:45 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

8. Okt. 2025, 23:43 UTC

Market Talk

Gold Falls on Possible Profit-Taking -- Market Talk

8. Okt. 2025, 23:18 UTC

Akquisitionen, Fusionen, Übernahmen

JD Logistics to Finance Acquisition Using Internal Funds

8. Okt. 2025, 23:17 UTC

Akquisitionen, Fusionen, Übernahmen

JD Logistics to Buy On-Demand Delivery Services Business for US$270.0M

8. Okt. 2025, 23:16 UTC

Akquisitionen, Fusionen, Übernahmen

JD Logistics to Buy JD.com's On-Demand Delivery Services Business Dajiang and Dasheng

8. Okt. 2025, 21:54 UTC

Market Talk
Ergebnisse

James Hardie Could Beat Annual Earnings Goal -- Market Talk

8. Okt. 2025, 21:30 UTC

Market Talk

Boab Metals Bull Delivers Second Upgrade in a Month -- Market Talk

8. Okt. 2025, 21:26 UTC

Market Talk
Ergebnisse

Transurban's 1Q Traffic Growth Beats Hopes -- Market Talk

8. Okt. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. Okt. 2025, 19:15 UTC

Market Talk

Geopolitical Risk Supports Gains in Oil Futures -- Market Talk

8. Okt. 2025, 19:01 UTC

Market Talk

U.S. Natural Gas Futures Pull Back Ahead of Storage Data -- Market Talk

8. Okt. 2025, 18:47 UTC

Market Talk

Coca-Cola North America Sales Buoy International Weakness -- Market Talk

8. Okt. 2025, 18:46 UTC

Akquisitionen, Fusionen, Übernahmen

TaskUs: Neither Party Will Be Required to Pay Termination Fee as Result of Planned Mutual Decision to Terminate

8. Okt. 2025, 18:46 UTC

Akquisitionen, Fusionen, Übernahmen

TaskUs Will Remain a Publicly Traded Co >TASK

8. Okt. 2025, 18:46 UTC

Akquisitionen, Fusionen, Übernahmen

TaskUs Does Not Plan to Convene Another Special Meeting of Stockholders >TASK

8. Okt. 2025, 18:45 UTC

Akquisitionen, Fusionen, Übernahmen

TaskUs Didn't Receive Votes Necessary to Approve Transaction Agreement With Affil of Blackstone >TASK

8. Okt. 2025, 18:07 UTC

Market Talk

Mexico's Inflation Seen Edging Up in September -- Market Talk

8. Okt. 2025, 16:20 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Energy & Utilities Roundup: Market Talk

8. Okt. 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. Okt. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8. Okt. 2025, 15:57 UTC

Market Talk

Oil Rises Despite U.S. Crude Stockpiles Build -- Market Talk

8. Okt. 2025, 15:56 UTC

Market Talk

Teck Resources' Chile Mine Issues Appear Transitory -- Market Talk

8. Okt. 2025, 15:53 UTC

Market Talk

Argentine Sovereign Debt Seen as Attractive -- Market Talk

8. Okt. 2025, 15:44 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical: Broadwood's Proposal to Vote Down Merger Could Allow It to Take Control Without Paying Any Premium

8. Okt. 2025, 15:44 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical Board and Management Disagree With Recommendation Issued by Glass Lewis >STAA

8. Okt. 2025, 15:43 UTC

Akquisitionen, Fusionen, Übernahmen

STAAR Surgical Board Reiterates Unanimous Recommendation Holders Vote for Alcon Merger

8. Okt. 2025, 15:42 UTC

Akquisitionen, Fusionen, Übernahmen

Oracle Is a Buy-the-Dip Opportunity, Analyst Says. How the Stock Could Rise 23%. -- Barrons.com

Peer-Vergleich

Kursveränderung

Guardant Health Inc Prognose

Kursziel

By TipRanks

9.32% Vorteil

12-Monats-Prognose

Durchschnitt 69.35 USD  9.32%

Hoch 80 USD

Tief 60 USD

Basierend auf 22 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Guardant Health Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

22 ratings

21

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

38.86 / 47.41Unterstützung & Widerstand

Kurzfristig

Very Strong Bearish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Bullish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
help-icon Live chat